CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 183 filers reported holding CARA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $506,325 | -37.2% | 301,384 | +5.8% | 0.00% | – |
| Q2 2023 | $805,901 | +46.7% | 284,771 | +154.6% | 0.00% | – |
| Q1 2023 | $549,198 | -44.2% | 111,853 | +22.0% | 0.00% | – |
| Q4 2022 | $984,858 | -48.2% | 91,700 | -54.9% | 0.00% | – |
| Q3 2022 | $1,901,000 | +53.2% | 203,126 | +49.5% | 0.00% | – |
| Q2 2022 | $1,241,000 | -39.6% | 135,883 | -19.7% | 0.00% | – |
| Q1 2022 | $2,056,000 | -80.6% | 169,240 | -80.6% | 0.00% | – |
| Q4 2021 | $10,620,000 | +10.7% | 871,936 | +40.5% | 0.00% | -100.0% |
| Q3 2021 | $9,591,000 | +87.8% | 620,750 | +73.5% | 0.00% | – |
| Q2 2021 | $5,107,000 | -17.9% | 357,818 | +24.9% | 0.00% | – |
| Q1 2021 | $6,221,000 | -52.1% | 286,538 | -66.6% | 0.00% | – |
| Q4 2020 | $12,976,000 | +127.9% | 857,678 | +91.7% | 0.00% | – |
| Q3 2020 | $5,694,000 | -27.7% | 447,456 | -2.8% | 0.00% | -100.0% |
| Q2 2020 | $7,873,000 | +65.3% | 460,400 | +27.7% | 0.00% | 0.0% |
| Q1 2020 | $4,762,000 | -56.9% | 360,489 | -47.4% | 0.00% | -33.3% |
| Q4 2019 | $11,039,000 | +45.4% | 685,245 | +65.0% | 0.00% | +50.0% |
| Q3 2019 | $7,591,000 | -90.6% | 415,258 | -88.9% | 0.00% | -80.0% |
| Q2 2019 | $80,521,000 | +534.8% | 3,745,118 | +479.3% | 0.01% | +100.0% |
| Q1 2019 | $12,684,000 | +100.9% | 646,482 | +33.1% | 0.01% | +150.0% |
| Q4 2018 | $6,313,000 | -64.9% | 485,590 | -35.4% | 0.00% | -66.7% |
| Q3 2018 | $17,994,000 | -8.2% | 751,303 | -26.6% | 0.01% | -14.3% |
| Q2 2018 | $19,610,000 | +66.9% | 1,024,044 | +7.9% | 0.01% | +75.0% |
| Q1 2018 | $11,747,000 | +24.5% | 948,867 | +23.1% | 0.00% | +33.3% |
| Q4 2017 | $9,437,000 | -21.3% | 770,956 | -12.0% | 0.00% | -40.0% |
| Q3 2017 | $11,995,000 | -31.8% | 876,140 | -23.3% | 0.01% | -28.6% |
| Q2 2017 | $17,583,000 | -38.8% | 1,142,500 | -26.8% | 0.01% | -53.3% |
| Q1 2017 | $28,718,000 | +1296.1% | 1,561,600 | +605.3% | 0.02% | – |
| Q4 2016 | $2,057,000 | +120.7% | 221,412 | +98.3% | 0.00% | – |
| Q3 2016 | $932,000 | +771.0% | 111,662 | +403.3% | 0.00% | – |
| Q2 2016 | $107,000 | -51.6% | 22,188 | -37.6% | 0.00% | – |
| Q1 2016 | $221,000 | -65.1% | 35,536 | -5.6% | 0.00% | – |
| Q4 2015 | $634,000 | -21.2% | 37,657 | -33.1% | 0.00% | – |
| Q3 2015 | $805,000 | +42.0% | 56,309 | +20.7% | 0.00% | – |
| Q2 2015 | $567,000 | +397.4% | 46,642 | +307.2% | 0.00% | – |
| Q4 2014 | $114,000 | – | 11,454 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,204,449 | $10,824 | 1.35% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,233,000 | $6,054,030 | 1.14% |
| Chescapmanager LLC | 1,160,392 | $5,698 | 0.90% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,732,375 | $8,505,961 | 0.22% |
| XTX Topco Ltd | 107,610 | $528,365 | 0.11% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 84,530 | $415,042 | 0.08% |
| PINNACLE ASSOCIATES LTD | 679,413 | $3,335,918 | 0.07% |
| PDT Partners, LLC | 102,010 | $500,869 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,370 | $9,797,267 | 0.05% |
| AXQ CAPITAL, LP | 27,760 | $136,302 | 0.05% |